IntelGenx and Aquestive Therapeutics Enter Worldwide Collaboration Agreement for Tadalafil Pharmaceutical Investing
Mustang Bio Announces City of Hope Opens First-of-Its-Kind Multiple Myeloma CAR T Cell Therapy Trial Targeting CS1 Protein Biotech Investing
Aura Announces Supply Agreement With FSD Pharma & Conditions Met to Close German Acquisition Cannabis Investing News
TG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis Biotech Investing
Ritter Pharmaceuticals Completes Dosing of Last Patient in Pivotal 557-Subject Phase 3 Clinical Trial Pharmaceutical Investing
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
